KRAS and lung adenocarcinoma: In fact, in cancers with frequent KRAS mutations, including PDAC, lung adenocarcinoma (LAUD) and colon adenocarcinoma (COAD), PTRH1 mRNA expression was significantly negatively correlated with KRAS mRNA levels (Additional file 10: Fig. S10).